Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Egetis Therapeutics AB (publ)

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 46,100 More Arrow 57,600 Less Arrow 22,600
Financial expenses 30,300 Less Arrow 6,900 Less Arrow 700
Earnings before taxes -343,200 More Arrow -326,800 More Arrow -193,800
EBITDA -325,900 More Arrow -321,200 More Arrow -195,400
Total assets 792,300 Less Arrow 760,200 Less Arrow 561,100
Current assets 380,100 Less Arrow 345,900 Less Arrow 147,400
Current liabilities 204,200 Less Arrow 103,900 Less Arrow 49,400
Equity capital 492,900 More Arrow 545,600 Less Arrow 506,200
- share capital 20,400 Less Arrow 15,400 Less Arrow 11,300
Employees (average) 35 Less Arrow 27 Less Arrow 15

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 62.2% More Arrow 71.8% More Arrow 90.2%
Turnover per employee 1,317 More Arrow 2,133 Less Arrow 1,507
Profit as a percentage of turnover -744.5% More Arrow -567.4% Less Arrow -857.5%
Return on assets (ROA) -39.5% Less Arrow -42.1% More Arrow -34.4%
Current ratio 186.1% More Arrow 332.9% Less Arrow 298.4%
Return on equity (ROE) -69.6% More Arrow -59.9% More Arrow -38.3%
Change turnover -11,500 More Arrow 35,000 Less Arrow -15,643
Change turnover % -20% More Arrow 155% Less Arrow -41%
Chg. No. of employees 8 More Arrow 12 Less Arrow 4
Chg. No. of employees % 30% More Arrow 80% Less Arrow 36%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.